BioSpace News Archive

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that Company management will be participating in three upcoming investor conferences.

Aquestive Therapeutics, Inc. today announced the refinancing of its existing debt facility.

X4 Pharmaceuticals, Inc. announced that it will be reporting financial results for the third quarter ended September 30, 2023 and providing corporate updates on Thursday, November 9, 2023.

LENSAR, Inc. today announced that the Company’s third quarter 2023 financial results will be released before market open on Thursday, November 9, 2023.

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (“Bausch Health” or the “Company” or “we” or “our”) today announced its third-quarter 2023 financial results and other key updates from the quarter.

Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company, today announced that it has entered a revenue sharing license and commercialization agreement (the “Agreement”) with Quadri Pharmaceuticals Store LLC (Quadri Pharma) that grants Quadri Pharma exclusive promotional, commercialization, and distribution rights for the rare disease indications of microvillus inclusion disease.

Lexicon Pharmaceuticals, Inc. announced that five data presentations related to INPEFA® will be delivered during the American Heart Association Scientific Sessions 2023, November 11-13, 2023, at the Pennsylvania Convention Center in Philadelphia, PA.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced educational opportunities and product updates at the American Academy of Ophthalmology Annual Meeting on November 3 – 6 in San Francisco.

Keros Therapeutics, Inc. announced that five abstracts will be presented from its hematology program at the 65th American Society of Hematology Annual Meeting and Exposition to be held in person and virtually from December 9 through 12, 2023.

Disc Medicine, Inc. announced several key updates and that it will present data from multiple programs in its hematology portfolio at the upcoming 65th American Society of Hematology Annual Meeting and Exposition, which will be held in San Diego, CA on December 9-12, 2023.